- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04318184
Effects of Exercise on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus
First Exercise Reports of Diabetes Centre: Effects of Exercise on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The data of the participants who came to the sports center where is prepared for the diabetes patients in the hospital will be collected from the past registration files on the electronic system.
Sociodemographic data, blood values and bio-impedance measurements of each patient are collected coming to the sports center, routinely.
Patients who had missing data, patients who did not complete the 3-month exercise program were excluded from the analysis. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 22. 0 for Windows. Data are expressed as mean ± standard deviation. The one-sample Kolmogorov-Smirnov test was performed to assess the distribution of data. Due to their distribution, numerical variables in different subjects were compared with the t-test or Mann-Whitney U test. Comparison of variables before and after the exercise program were compared by the paired t-test (parametric variable) or Wilcoxon test (non-parametric variable). Probability values were two-tailed, and a p-value of less than 0.05 was considered as significant.
All assessments were performed in the clinic at baseline and end of the 3rd month. The blood samples were collected. The systolic and diastolic blood pressure (SBP and DBP) were measured with an automatic arm BP monitor before and after every session. Body mass and body composition, including percent body fat, fat and fat-free mass, were determined using a bioelectric impedance system with the electrodes in contact with soles and heels of both feet. At the baseline and end of the third month, the same person repeated all assessments.
Patients had recruited 3 sessions a week for 3 months (Monday/Wednesday/Friday). Every session consisted of aerobic exercise protocol and warm-up, cooldown period. Patients aerobic loading capacity was calculated before the every session using by Karvonen formula as submaximal loading.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Istanbul, Truthahn
- Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Persons who were diagnosed with DM,
- Aged between 18 and 65 years,
- Patients who completed the three-month exercise program.
Exclusion Criteria:
- Had chronic drug (antidiabetic and antilipidemic) adjustments for 3 months at the beginning and during the exercise program,
- Participated in an exercise program before,
- Had a health condition other than DM associated with glucose metabolism.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Exercise
Submaximal aerobic exercise protocol
|
The aerobic exercise protocol was performed 3 times a week for 3 months on the treadmill.
Loading periods were performed according to the heart rate maximum using the Karvonen formula (%60-80 Heart rate maximum)
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
"Change" is being assessed for HbA1c
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed Total Cholesterol
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed for LDL
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed for HDL
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed for Blood Glucose
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed for Post prandial glucose
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
"Change" is being assessed for Triglyceride
Zeitfenster: Baseline and end of the 3rd month
|
Blood parameters
|
Baseline and end of the 3rd month
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
"Change" is being assessed for Blood Pressure
Zeitfenster: Baseline and end of the 3rd month
|
Sistolic and Diastolic Pressure
|
Baseline and end of the 3rd month
|
"Change" is being assessed for Fat Mass (kg)
Zeitfenster: Baseline and end of the 3rd month
|
Evaluation with bio-empedans device (TANITA)
|
Baseline and end of the 3rd month
|
"Change" is being assessed for Muscle Mass (kg)
Zeitfenster: Baseline and end of the 3rd month
|
Evaluation with bio-empedans device (TANITA)
|
Baseline and end of the 3rd month
|
"Change" is being assessed for BMI
Zeitfenster: Baseline and end of the 3rd month
|
Evaluation with bio-empedans device (TANITA)
|
Baseline and end of the 3rd month
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 17073117-050.06
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Diabetes mellitus, Typ 2
-
SanofiAbgeschlossenDiabetes mellitus Typ 1 – Diabetes mellitus Typ 2Ungarn, Russische Föderation, Deutschland, Polen, Japan, Vereinigte Staaten, Finnland
-
University Hospital Inselspital, BerneAbgeschlossen
-
US Department of Veterans AffairsAmerican Diabetes AssociationAbgeschlossenTyp 2 Diabetes mellitusVereinigte Staaten
-
AstraZenecaRekrutierung
-
Daewoong Pharmaceutical Co. LTD.Noch keine RekrutierungT2DM (Typ-2-Diabetes mellitus)
-
Zhongda HospitalRekrutierungTyp-2-Diabetes mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RekrutierungT2DM (Typ-2-Diabetes mellitus)China
-
Shanghai Golden Leaf MedTec Co. LtdAktiv, nicht rekrutierendTyp-2-Diabetes mellitus (T2DM)China
-
SanofiAbgeschlossen
-
Haisco Pharmaceutical Group Co., Ltd.AbgeschlossenT2DM (Typ-2-Diabetes mellitus)China